Sep 23, 2022 / 07:00AM GMT
Operator
Hello, and welcome to the Mithra half year results 2022 call. My name is Rian, and I'll be your coordinator for today's event. (Operator Instructions)
I'll now hand you over to your host, Benoit Mathieu to begin today's conference. Thank you.
Benoit Mathieu - Mithra Pharmaceuticals SA - Group IR Manager
Good morning, ladies and gentlemen. My name is Benoit Mathieu, Group Investor Relations Manager at Mithra. Thank you all for dialing into this conference call and for being with us for the presentation of our half year results 2022. I am joined in the room by our CEO, Mr. Leon Van Rompay; Mr. Christophe Marechal, CFO; Mr. Graham Dixon, CEO -- CSO, sorry; and Mr. Jean-Manuel Fontaine, Chief Commercial Officer.
This webcast is recorded and will be accessible later today on Mithra's website. I would like to remind you that this webcast is covered by the disclaimer on Slide 2 of the presentation. The format of today's call will be as follows. A brief introduction will be given by Leon before handing over to Christophe for the explanation of the
Q2 2022 Mithra Pharmaceuticals SA Earnings Call Transcript
Sep 23, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers